Program Curriculum 

Our pharmacy residency program provides a strong foundation for residents to build their clinical skills at training sites that value inter-professional collaboration and medical education. Residents will participate in providing care to a diverse population of patients and addressing the healthcare needs of the Central Valley. 

Required learning experiences are scheduled at each resident’s respective home-based site while elective learning experiences are available to all residents at both sites. Each rotation’s duration is 4-6 weeks. 

Learning Experiences

Required Rotations

• Hospital Operations I/II
• Internal Medicine
• Intensive Care Unit (ICU)
• Emergency Medicine
• Hospital Administration

Elective Rotations

• Medication Safety
• Clinical Informatics
• Supply Chain Management
• Quality/Risk Management
• Burn/Surgery ICU
• Neuro ICU
• Trauma/Surgery ICU
• Pediatrics
• Neonatal ICU
• Infectious Diseases
• Inpatient Oncology
• Outpatient Oncology
• Women & Children’s

Longitudinal Resident Projects

• Pharmacy Education Seminar (1.0 CE accredited)
• Drug Monograph
• Research
• Hospital Operations Staffing

Additional Resident Opportunities

• Teaching Certificate
• Basic Life Support (BLS) Training & Certification
• Advanced Cardiac Life Support (ACLS) Training & Certification
• Pediatric Advanced Life Support (PALS) Training & Certification

Previously Completed Longitudinal Resident Projects

Pharmacy Education Seminars (1.0 CE accredited)

• “Role of DOACs in Valvular Atrial Fibrillation”
• “Antimicrobial Prophylaxis and Treatment of Cancer Related Infections”
• “Immunotherapy Cytokines Release Syndrome + Neurotoxicity Management”
• “Beyond the Pill: Elevating Patient Care through Medication Safety Excellence”
• Pharmacy Department – “Vancomycin Quality Assurance Project”

Drug Monographs

• Rezafungin (Rezzayo®)
• Ivosidenib (Tibsovo®)
• Artemether/Lumefantrine (Coartem®)
• MUE on lipid utilization within Community Medical Centers

Research

• Efficacy and safety of IV ketamine infusion use for pain and sedation in the ICU
• Evaluation of adherence to the 2020 CDC treatment guideline update for gonorrhea and chlamydia in adults presenting to the emergency department
• Outcomes for patients on midazolam based sedation vs. non-midazolam based sedation in paralyzed ARDS patients
• Evaluation of the safety and efficacy of intra-arterial (IA) verapamil vs IA nicardipine for the treatment of vasospasm in aneurysmal subarachnoid hemorrhage (aSAH)